CN103145542B - Method for producing difluorobenzene derivative - Google Patents

Method for producing difluorobenzene derivative Download PDF

Info

Publication number
CN103145542B
CN103145542B CN201310004873.5A CN201310004873A CN103145542B CN 103145542 B CN103145542 B CN 103145542B CN 201310004873 A CN201310004873 A CN 201310004873A CN 103145542 B CN103145542 B CN 103145542B
Authority
CN
China
Prior art keywords
formula
carbonatoms
solvent
compound
dicyclo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310004873.5A
Other languages
Chinese (zh)
Other versions
CN103145542A (en
Inventor
松本隆
齐藤佳孝
岩洼昌幸
佐藤纱绘子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shijiazhuang Chengzhi Yonghua Display Material Co Ltd
DIC Corp
Original Assignee
Dainippon Ink and Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Ink and Chemicals Co Ltd filed Critical Dainippon Ink and Chemicals Co Ltd
Publication of CN103145542A publication Critical patent/CN103145542A/en
Application granted granted Critical
Publication of CN103145542B publication Critical patent/CN103145542B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

The invention provides a method for producing difluorobenzene derivative, and relates to an efficiently producing method of the difluorobenzene derivative containing thiazolinyl on a side chain and an intermediate usable for the production method. Especially, the invention provides a compound represented by a general formulae (3).

Description

The preparation method of difluoro bezene derivative
The present invention is to be the divisional application that March 30, application number in 2007 are 201010105726.3, denomination of invention is " preparation method of difluoro bezene derivative " applying date.
Technical field
The present invention relates to a kind of preparation method of difluoro bezene derivative and prepare intermediate.
Background technology
Liquid crystal display device, due to advantages such as it is low voltage operated, slim demonstrations, is nowadays widely used.The display mode of liquid crystal display device had TN(twisted-nematic in the past), STN(supertwist is to row), or the active-matrix (active-matrix) (TFT: thin film transistor) that forms on substrate of TN etc., they are all that to utilize dielectric constant anisotropy value be positive liquid-crystal composition.But it is that its visual angle is narrower that these display modes have a shortcoming, the raising requiring along with liquid crystal board maximization in recent years, improves this problem and becomes larger problem.
As its solution, vertical orientation mode, IPS(In Plane Switching transverse electric field effect in recent years) etc. display mode start to be practical.Vertical orientation mode is utilize liquid crystal molecule vertical orientated to improve the method at visual angle, use be that dielectric constant anisotropy value is negative liquid-crystal composition.IPS in addition, is to use transverse electric field conversion liquid crystal molecule to improve the method at visual angle in the horizontal direction of relative glass substrate, use be the liquid-crystal composition that dielectric constant anisotropy value is negative or positive.So, in the vertical orientation mode of effective display mode at visual angle and IPS, all to need dielectric constant anisotropy value be negative liquid crystalline cpd and liquid-crystal composition can improve, and urgent hope can be achieved.
Be the liquid crystalline cpd using in negative liquid-crystal composition as dielectric constant anisotropy value, can enumerate 2,3-difluorophenyl derivative (with reference to patent documentation 1).But only disclosing side chain in patent documentation 1 is amino compound, the compound that openly side chain is not thiazolinyl completely, its preparation method is not known yet.In addition, there is the compound of alkoxyl group on 1 and 4 of known phenyl ring because therefore chemically unstable does not use (with reference to non-patent literature 1) as liquid crystal material, therefore the exploitation of this compounds process for production thereof is not carried out.
Patent documentation 1: special public table 2-503568 communique
Non-patent literature 1: field, natural pond, " trend of liquid crystal material ", monthly magazine デ イ ス プ レ イ, in March, 1998, the 4th volume, No. 3 (page 5)
Summary of the invention
The invention provides and on side chain, have the used intermediate of preparing in the effective preparation method of the difluoro bezene derivative of thiazolinyl and this preparation method.
The inventor attentively studies for solving above-mentioned problem, found that the method by compound shown in formula (1) being converted to compound shown in formula (2), can effectively prepare the difluoro bezene derivative on side chain with thiazolinyl, thereby complete the present invention.
The present invention relates to,
The compound represented by formula (1) reacts compound shown in the formula of obtaining (2) with the phenates being made by 2,3-difluorophenol;
After compound oxidation shown in this formula (2), obtain compound shown in formula (13);
The phenates being made by compound shown in this formula (13) reacts with compound shown in formula (7), obtains compound shown in formula (16);
After compound deprotection shown in this formula (16), obtain compound shown in formula (17);
In compound and methoxymethyl phosphine shown in this formula (17), after reactant salt, hydrolyzable obtains compound shown in formula (18);
In compound and alkylphosphines shown in this formula (18), reactant salt obtains the preparation method of compound shown in formula (9),
And,
Compound shown in formula (1) obtains compound shown in formula (2) with the phenates reaction being made by 2,3-difluorophenol;
After compound deprotection shown in this formula (2), obtain compound shown in formula (3);
In compound and methoxymethyl phosphine shown in this formula (3), after reactant salt, hydrolyzable obtains compound shown in formula (4);
In compound and alkylphosphines shown in this formula (4), reactant salt obtains compound shown in formula (5);
After compound oxidation shown in this formula (5), obtain compound shown in formula (6);
The phenates being made by compound shown in this formula (6) reacts with compound shown in formula (7), obtains the preparation method of compound shown in formula (9).
Figure BDA00002712071900031
R 4X 2 (7)
Figure BDA00002712071900032
Figure BDA00002712071900041
Wherein,
In formula (1), (2), (13), (16), R 1and R 2represent independently methyl, ethyl or propyl group separately, or, R 1and R 2expression-CH 2cH 2-,-CH 2cH 2cH 2-or-CH 2c (CH 3) 2cH 2-;
In formula (1), X 1represent chlorine, bromine, iodine, phenylsulfonyloxy, tolysulfonyl oxygen base, methanesulfonyloxy group or trifluoromethane sulfonyloxy;
In formula (5), (6), (9), R 3represent the alkyl of hydrogen atom or carbonatoms 1 to 5;
In formula (7), X 2represent chlorine, bromine, iodine, phenylsulfonyloxy, tolysulfonyl oxygen base, methanesulfonyloxy group or trifluoromethane sulfonyloxy;
In formula (7), (9), (16), (17), (18), R 4represent thiazolinyl or the expression (8) of carbonatoms 2 to 12;
In formula (8), R 5for the alkyl of carbonatoms 1 to 12, the thiazolinyl of carbonatoms 2 to 12, the alkoxyl group of carbonatoms 1 to 12, the alkene oxygen base of carbonatoms 2 to 12.
Further, the invention provides the used intermediate of preparing in preparation process of the present invention, by compound shown in formula (2), (3), (4), (5), (6), (13), (16), (17) and (18).
Preparation method of the present invention, as the preparation method of difluoro bezene derivative of great use.In addition, preparation method of the present invention is owing to having introduced side chain R in final step 3or R 4, can extremely easily synthesize and only have R 3or R 4compound group shown in different formulas (9).
Embodiment
In preparation method of the present invention, 2,3-difluorophenol and alkali effect generate phenates, then react compound shown in the formula of obtaining (2) with compound shown in formula (1), the alkali using can be enumerated metal hydride, metal carbonate, metal phosphate, metal hydroxides, metal carboxylate, metal amide and metal etc., wherein preferred as alkali hydride, alkali metal phosphate, alkali metal phosphate, alkaline carbonate, alkali metal hydroxide, alkali metal amide, basic metal; Further preferred as alkali phosphoric acid salt, alkalimetal hydride, alkaline carbonate.The preferred lithium hydride of alkalimetal hydride, sodium hydride, potassium hydride KH, alkali metal phosphate preferably phosphoric acid tripotassium, the preferred sodium carbonate of alkaline carbonate, sodium bicarbonate, cesium carbonate, salt of wormwood, saleratus.
As reaction solvent, if be applicable to reaction carry out any all can, but preferably use ether solvent, chlorine kind solvent, varsol, aromatic series kind solvent, polar solvent etc.As ether solvent, can enumerate Isosorbide-5-Nitrae-bis-
Figure BDA00002712071900051
alkane, 1,3-bis-
Figure BDA00002712071900052
alkane, tetrahydrofuran (THF), Anaesthetie Ether, t-butyl methyl ether etc., can enumerate methylene dichloride, 1 as chlorine kind solvent, 2-ethylene dichloride, four salinization carbon etc., can enumerate amylene, hexene, tetrahydrobenzene, heptane, octane etc. as varsol, can enumerate benzene,toluene,xylene, trimethylbenzene, chlorobenzene, dichlorobenzene etc. as aromatic series kind solvent, polar solvent can be enumerated the example preferably such as DMF, N-Methyl pyrrolidone, dimethyl sulfoxide (DMSO), tetramethylene sulfone.Wherein be more preferably the polar solvent of ether solvent, the DMF etc. of tetrahydrofuran (THF), Anaesthetie Ether etc.In addition, each solvent of front note can be used alone, also can 2 kinds or above mixing use.
Though temperature of reaction can be carried out in the zero pour from solvent in reflow temperature range, preferably 0 DEG C to 150 DEG C, further preferably 30 DEG C to 120 DEG C.In addition, the phenates of generation can react with compound shown in formula (1) after flash liberation, also can not separate and react, but consider under not separating, to react better from the difficulty or ease of operation.
Shown in formula (2) or formula (16), the deprotection of compound preferably carries out under acidic conditions.The acid using, can enumerate the protonic acid of formic acid, acetic acid, trifluoroacetic acid, oxalic acid, tosic acid etc., the Lewis acid of boron trifluoride element etc. etc., but preferably use formic acid.
Reaction solvent, any as long as the carrying out that is applicable to reacting can be used, preferably use ether solvent, chlorine kind solvent, ketones solvent, varsol, aromatic series kind solvent, polar solvent etc., also can under solvent-free, react.Ether solvent, can enumerate Isosorbide-5-Nitrae-bis-
Figure BDA00002712071900053
alkane, 1,3-bis-
Figure BDA00002712071900054
alkane, tetrahydrofuran (THF), Anaesthetie Ether, t-butyl methyl ether etc., chlorine kind solvent has methylene dichloride, 1,2-ethylene dichloride, chloroform, four salinization carbon etc., ketones solvent can be enumerated acetone, 2-butanone etc., varsol can be enumerated amylene, hexene, tetrahydrobenzene, heptane, octane etc., aromatic series kind solvent can be enumerated benzene,toluene,xylene, trimethylbenzene, chlorobenzene, dichlorobenzene etc., and polar solvent can be enumerated the example preferably such as acetonitrile, dimethyl sulfoxide (DMSO).Wherein, be more preferably the varsol of amylene, hexene, tetrahydrobenzene, heptane, octane etc., the aromatic series kind solvent of benzene,toluene,xylene etc. etc.In addition, each solvent of front note can be used alone, also can 2 kinds or above solvent use.
Though temperature of reaction can be carried out in the zero pour from solvent in reflow temperature range, preferably 0 DEG C to 100 DEG C, further preferably 30 DEG C to 60 DEG C.
In compound and methoxymethyl phosphine shown in formula (3) or formula (17), hydrolyzable after reactant salt, can obtain compound shown in formula (4) from formula (3), can obtain compound shown in formula (18) from formula (17).Methoxymethyl phosphine inner salt can make from phosphonium salt, phosphoric acid ester etc., preferably makes from methoxymethyl triphenylphosphine salt.
While using methoxymethyl triphenylphosphine salt to prepare inner salt and alkali effect, the preferred potassium tert.-butoxide of alkali of use, n-Butyl Lithium, phenyl lithium, sodium hydride etc., be more preferably potassium tert.-butoxide.Reaction solvent preferably uses ether solvent, aromatic series kind solvent, polar solvent etc.Ether solvent can be enumerated Isosorbide-5-Nitrae-bis- alkane, 1,3-bis-
Figure BDA00002712071900062
alkane, tetrahydrofuran (THF), Anaesthetie Ether, t-butyl methyl ether etc., aromatic series kind solvent can be enumerated benzene,toluene,xylene, trimethylbenzene etc., and polar solvent can be enumerated DMF etc.Wherein be more preferably tetrahydrofuran (THF), toluene.In addition, each solvent of front note can be used alone, also can 2 kinds or above solvent use.
Temperature of reaction is carried out in can be from the zero pour of solvent to reflow temperature range, but preferably-40 DEG C to 30 DEG C, further preferably-20 DEG C to 20 DEG C.The inner salt obtaining preferably reacts with compound shown in formula (3) under unseparated situation.In addition, shown in methoxymethyl triphenylphosphine salt, formula (3), in the mixture of compound, also can add alkali.
Hydrolyzable can be carried out under acid catalyst.The acid using, can enumerate dilute hydrochloric acid, aqueous sulfuric acid etc.Reaction solvent, any as long as the carrying out that is applicable to reacting can be used, preferably use ether solvent, varsol, aromatic series kind solvent etc., also can under solvent-free, react.Ether solvent, can enumerate Isosorbide-5-Nitrae-bis- alkane, 1,3-bis-
Figure BDA00002712071900064
alkane, tetrahydrofuran (THF), Anaesthetie Ether, t-butyl methyl ether etc., varsol can be enumerated amylene, hexene, tetrahydrobenzene, heptane, octane etc., and aromatic series kind solvent can be enumerated benzene,toluene,xylene, trimethylbenzene, chlorobenzene, dichlorobenzene etc.Wherein, be more preferably tetrahydrofuran (THF).In addition, each solvent of front note can be used alone, also can 2 kinds or above solvent use.
Temperature of reaction is carried out in can be from the zero pour of solvent to reflow temperature range, preferably 0 DEG C to 80 DEG C.
Compound shown in the formula (4) so obtaining or formula (18), what obtain for cyclohexene ring is cis and trans mixture, but uses preferably trans as the intermediate of liquid crystalline cpd.For the cyclohexene ring of the combination formyloxy side of compound shown in formula (4) or formula (18), by making its cis-trans isomerization with alkali effect, thereby make trans surplus.The preferred sodium hydroxide of alkali, the potassium hydroxide etc. that now use, reaction solvent particular methanol, ethanol, tetrahydrofuran (THF) etc., preferably-40 DEG C to 20 DEG C of temperature of reaction, further preferred-20 DEG C to 10 DEG C.
Reactant salt in compound and alkylphosphines shown in formula (4) or formula (18), can obtain formula (5) from formula (4), obtains compound shown in ultimate aim product formula (9) from formula (18).In this reaction, alkylphosphines inner salt can make from phosphonium salt, phosphoric acid ester etc., preferably makes from alkyl triphenylphosphine salt.
In the time using alkyl triphenylphosphine salt to make inner salt and alkali effect, the preferred potassium tert.-butoxide of alkali of use, n-Butyl Lithium, phenyl lithium, sodium hydride etc., be more preferably potassium tert.-butoxide.Reaction solvent preferably uses ether solvent, aromatic series kind solvent, polar solvent etc.Ether solvent, can enumerate Isosorbide-5-Nitrae-bis-
Figure BDA00002712071900071
alkane, 1,3-bis- alkane, tetrahydrofuran (THF), Anaesthetie Ether, t-butyl methyl ether etc., aromatic series kind solvent can be enumerated benzene,toluene,xylene, trimethylbenzene etc., and polar solvent can be enumerated DMF etc., is wherein more preferably tetrahydrofuran (THF), toluene.In addition, each solvent of front note can use separately, also can 2 kinds or above solvent use.Temperature of reaction is carried out in can be from the zero pour of solvent to reflow temperature range, preferably from-40 DEG C to 30 DEG C, and further preferably-20 DEG C to 20 DEG C.The inner salt of gained preferably reacts with compound shown in formula (4) under unseparated situation.In addition, shown in alkyl triphenylphosphine salt, formula (4), in the mixture of compound, also can add alkali.Alkyl triphenylphosphine salt is preferably used methyl triphenyl phosphonium salt.
The oxidation of compound shown in formula (2) or formula (5), reacts and obtains boron compound with trialkyl borate after can utilizing the de-proton of organometallic reagent, then with oxygenant effect.Reaction solvent, as long as carrying out of being applicable to reacting is any all passable, can enumerate ether solvent, varsol etc.As ether solvent, can enumerate Isosorbide-5-Nitrae-bis-
Figure BDA00002712071900073
alkane, 1,3-bis-
Figure BDA00002712071900074
alkane, tetrahydrofuran (THF), Anaesthetie Ether, t-butyl methyl ether etc., varsol can be enumerated amylene, hexene, tetrahydrobenzene, heptane, octane etc., wherein preferred tetrahydrofuran (THF).Organometallic reagent can be enumerated n-Butyl Lithium, s-butyl lithium, tert-butyl lithium, lithium methide, lithium diisopropylamide etc., from the viewpoint of obtaining and operate the preferred n-Butyl Lithium of difficulty or ease, s-butyl lithium, because effective deprotonation is more preferably s-butyl lithium.In addition, when deprotonation, also can add the potassium tert.-butoxide as additive, the alkali such as tetramethylethylened together with above-mentioned organometallic reagent.Preferably-100 DEG C to-20 DEG C of temperature of reaction when deprotonation, further preferred-78 DEG C to-40 DEG C.
Trialkyl borate, preferably uses trimethyl borate.Preferably-100 DEG C to-20 DEG C of temperature of reaction when boronation, further preferred-78 DEG C to-40 DEG C.The boron compound obtaining can flash liberation, also can not separate directly and oxidant reaction.In addition, after the boron compound hydrolyzable obtaining, change into after boronic acid compounds also passable with oxidant reaction again.
Oxygenant, preferably uses hydrogen peroxide, peracetic acid or peroxyformic acid.Preferably-78 DEG C to 70 DEG C of temperature of reaction, further preferably 0 DEG C to 50 DEG C.In addition, during with oxidant reaction, solvent comprises water also has no relations.
Shown in formula (1), formula (2), formula (13) and formula (16), in compound, carbonyl utilizes R 1and R 2protect.R 1and R 2independent is separately methyl, ethyl or propyl group, or, R 1and R 2expression-CH 2cH 2-,-CH 2cH 2cH 2-or-CH 2c (CH 3) 2cH 2-, work as R 1and R 2for-CH 2cH 2-,-CH 2cH 2cH 2-or-CH 2c (CH 3) 2cH 2in-time, the concrete formula that formula (1) is recorded is as follows.
In formula (1), preferably R 1and R 2be methyl, or R 1and R 2for-CH 2cH 2-or-CH 2cH 2cH 2-.X 1and X 2for chlorine, bromine, iodine, phenylsulfonyloxy, tolysulfonyl oxygen base, methanesulfonyloxy group or trifluoromethane sulfonyloxy, preferably bromine or methanesulfonyloxy group.R 4for the thiazolinyl of carbonatoms 2 to 12, preferably 3-butenyl and 4-pentenyl.R 5for the alkyl of carbonatoms 1 to 12, the thiazolinyl of carbonatoms 2 to 12, the alkoxyl group of carbonatoms 1 to 12, the alkene oxygen base of carbonatoms 2 to 12, the preferably alkyl of carbonatoms 1 to 12 or the thiazolinyl of carbonatoms 2 to 12, the alkyl of further preferred carbonatoms 1 to 7.
The present invention is further specifically preferably as follows described compound suc as formula the intermediate of preparing of (2).
Figure BDA00002712071900082
Wherein compound shown in further preferred formula (2a), formula (2b) or formula (2d).
R in formula (5) 3for the alkyl of hydrogen atom or carbonatoms 1 to 5, preferably hydrogen atom or methyl, more preferably hydrogen atom.
R in formula (6) 3for the alkyl of hydrogen atom or carbonatoms 1 to 5, preferably hydrogen atom or methyl, more preferably hydrogen atom.
The present invention suc as formula (13) prepare intermediate be further specifically preferably as follows shown in compound.
Figure BDA00002712071900091
Wherein compound shown in further preferred formula (13a), formula (13b) or formula (13d).
The present invention's intermediate of preparing as the formula (16) is further preferably as follows formula (16a) to compound shown in formula (16l).
Figure BDA00002712071900092
In formula, R 6for the thiazolinyl of carbonatoms 2 to 12.
Formula (16a) arrives in formula (16f), R 6concrete is preferably 3-butenyl, 3-pentenyl, 4-pentenyl or 4-hexenyl, further preferred 3-butenyl or 4-pentenyl.
In formula, R 5for the alkyl of carbonatoms 1 to 12, thiazolinyl, the alkoxyl group of carbonatoms 1 to 12 or the alkene oxygen base of carbonatoms 2 to 12 of carbonatoms 2 to 12.
Formula (16g) arrives in formula (16l), R 5be preferably the alkyl of carbonatoms 1 to 7, thiazolinyl, the alkoxyl group of carbonatoms 1 to 7 or the alkene oxygen base of carbonatoms 2 to 7 of carbonatoms 2 to 7, the alkyl of further preferred carbonatoms 1 to 5, thiazolinyl, the alkoxyl group of carbonatoms 1 to 5 or the alkene oxygen base of carbonatoms 2 to 5 of carbonatoms 2 to 5, the particularly preferably thiazolinyl of the alkyl of carbonatoms 1 to 5 or carbonatoms 2 to 5.Thiazolinyl preferred vinyl, 1-propenyl, 3-butenyl or 3-pentenyl, particularly preferably vinyl.
The present invention's intermediate of preparing as the formula (17) is further specifically preferably as follows compound shown in formula (17a) and formula (17b).
Figure BDA00002712071900102
In formula, R 6for the thiazolinyl of carbonatoms 2 to 12, R 5for the alkyl of carbonatoms 1 to 12, thiazolinyl, the alkoxyl group of carbonatoms 1 to 12 or the alkene oxygen base of carbonatoms 2 to 12 of carbonatoms 2 to 12.
In formula (17a), R 6concrete is preferably 3-butenyl, 3-pentenyl, 4-pentenyl or 4-hexenyl, further preferred 3-butenyl or 4-pentenyl.
In formula (17b), R 5be preferably the alkyl of carbonatoms 1 to 7, thiazolinyl, the alkoxyl group of carbonatoms 1 to 7 or the alkene oxygen base of carbonatoms 2 to 7 of carbonatoms 2 to 7, the more preferably alkoxyl group of the thiazolinyl of the alkyl of carbonatoms 1 to 5, carbonatoms 2 to 5, carbonatoms 1 to 5 or the alkene oxygen base of carbonatoms 2 to 5, is particularly preferably the alkyl of carbonatoms 1 to 5 or the thiazolinyl of carbonatoms 2 to 5.Thiazolinyl preferred vinyl, 1-propenyl, 3-butenyl or 3-pentenyl, particularly preferably vinyl.
The present invention as the formula (18) prepare compound shown in the concrete formula that is preferably as follows (18a) of intermediate and formula (18b).
Figure BDA00002712071900111
In formula, R 6for thiazolinyl, the R of carbonatoms 2 to 12 5for the alkyl of carbonatoms 1 to 12, thiazolinyl, the alkoxyl group of carbonatoms 1 to 12 or the alkene oxygen base of carbonatoms 2 to 12 of carbonatoms 2 to 12.
In formula (17a), R 6concrete is preferably 3-butenyl, 3-pentenyl, 4-pentenyl or 4-hexenyl, more preferably 3-butenyl or 4-pentenyl.
In formula (17b), R 5be preferably thiazolinyl, the alkoxyl group of carbonatoms 1 to 7 or the alkene oxygen base of carbonatoms 2 to 7 of alkyl, the carbonatoms 2 to 7 of carbonatoms 1 to 7, the more preferably alkyl, thiazolinyl, the alkoxyl group of carbonatoms 1 to 5 or the alkene oxygen base of carbonatoms 2 to 5 of carbonatoms 2 to 5 of carbonatoms 1 to 5, the particularly preferably thiazolinyl of the alkyl of carbonatoms 1 to 5 or carbonatoms 2 to 5.Thiazolinyl preferred vinyl, 1-propenyl, 3-butenyl or 3-pentenyl, particularly preferably vinyl.
Embodiment
Below, enumerate embodiment and be described in further detail the present invention, but the present invention is not restricted to these embodiment.The structure of compound, can utilize nucleus magnetic resonance (NMR), and mass spectroscopy (MS) etc. is confirmed.
Utilize following abbreviation to describe compound.
THF: tetrahydrofuran (THF)
DMF:N, dinethylformamide
Me: methyl
Et: ethyl
Bu: butyl
Ph: phenyl
Ms: methane sulfonyl
Reference example
Initial substance of the present invention is compound shown in formula (1), can utilize for example following method preparation.
Figure BDA00002712071900121
In formula, R 1and R 2for representing the meaning identical with formula (1), Ms is methane sulfonyl.
Embodiment 1:4-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-2, synthetic 1 of the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (If)
1-1:3-[4, oneself-4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-1,2-difluorobenzene (Ia) synthetic
Figure BDA00002712071900122
Methanesulfonic (4, own-the 4 '-yl of 4-(ethylidene dioxy) dicyclo) methyl, 2,3-methylene fluoride sulfonic acid (4, own-the 4 '-yl of 4-(ethylidene dioxy) dicyclo) methyl esters 122.9g, 2,3-difluorophenol 49.5g, Tripotassium phosphate 235.4g and DMF 690mL mix, 3 stirrings hour at 80 DEG C.Filter reaction mixture, solid ingredient utilizes DMF to clean, and filters.Merging filtrate adds frozen water, and solid is separated out in leaching, in the mixed solvent of acetic acid ethyl, hexene, toluene, dissolves.Packed in column chromatography, desolventizing is heated up in a steamer in decompression, the refining 3-[4 that obtains 111.6g of residue recrystallize, own-the 4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-1,2-difluorobenzene (Ia).Compound (Ia), prepares intermediate of great use as liquid crystalline cpd.
MS m/z:366(M +)
1H-NMR(60MHz,CDCl 3)
δ:1.3–2.0(m,19H),3.8–4.0(m,6H),6.4–6.6(m,2H),6.8–7.0(m,1H)
1-2:4-[4, oneself-4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-2,3-difluorophenol (Ig) synthetic
Figure BDA00002712071900123
By the 3-[4 of 90g, own-the 4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-1,2-difluorobenzene (Ia) is dissolved in the THF of 540mL.At Nei Wen-60 DEG C, add secondary BuLi(1.0M tetrahydrobenzene solution) 260mL, stirs 2 hours.At Nei Wen-60 DEG C, add trimethyl borate 29g, be warming up to 20 DEG C.Add 15% hydrogen peroxide 72mL, at 35 DEG C, stir 5 hours.After adding 10% aqueous solution of sodium bisulfite, utilize 10% hydrochloric acid neutralization, divide and get after organic layer, with 400mL methylbenzene extraction water layer, merge organic layer and utilize 10% salt solution 250mL and water 250mL to clean, utilize anhydrous sodium sulfate drying.Desolventizing is heated up in a steamer in decompression, the refining 4-[4 that obtains of residue recrystallize, own-the 4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-2,3-difluorophenol (Ib) 87.9g.Compound (Ib), prepares intermediate of great use as liquid crystalline cpd.
MS m/z:382(M +)
1H-NMR(60MHz,CDCl 3)
δ:1.3–2.2(m,19H),3.8–4.0(m,6H),4.0–6.0(s,1H),6.3–6.5(m,2H)
1-3:4-[4, oneself-4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (Ih) synthetic
Figure BDA00002712071900131
By bromo-5-1-amylene, 4-[4, own-the 4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-2,3-difluorophenol (Ig), Tripotassium phosphate and DMF mix, and stir 2 hours at 130 DEG C.Add water, with methylbenzene extraction, after water and saturated aqueous common salt are cleaned organic layer, desolventizing is heated up in a steamer in decompression.Residue utilizes column chromatography and recrystallize to refine, and obtains 4-[4, own-the 4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (Ih).Compound (Ih), prepares intermediate of great use as liquid crystalline cpd.
MS m/z:450(M +)
1H-NMR(60MHz,CDCl 3)
δ:1.3–2.2(m,23H),3.8–4.0(m,8H),4.9–5.1(m,2H),5.6–5.8(m,1H),6.3–6.5(m,2H)
1-4:4-(dicyclo oneself-4-ketone-4 '-yl) methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (Ii) synthetic
Figure BDA00002712071900132
4-[4, own-the 4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-2, in the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (Ih), add toluene and formic acid, at 50 DEG C, stir 2 hours.Be cooled to after room temperature, add moisture and get organic layer, utilize methylbenzene extraction water layer.After merging organic layer and utilizing water, saturated sodium bicarbonate aqueous solution and saturated aqueous common salt to clean, utilize decompression after anhydrous magnesium sulfate drying to heat up in a steamer desolventizing.Residue recrystallize is refining obtains 4-(dicyclo oneself-4-ketone-4 '-yl) methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (Ii).Compound (Ii), prepares intermediate of great use as liquid crystalline cpd.
MS m/z:406(M +)
1H-NMR(60MHz,CDCl 3)
δ:1.6–2.0(m,19H),2.0–2.4(m,4H),3.8–4.0(m,4H),4.9–5.1(m,2H),5.6–5.8(m,1H),6.3–6.5(m,2H)
1-5:4-(anti-, trans-4-formyloxy dicyclo oneself-4 '-yl) methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (Ij) synthetic
Figure BDA00002712071900141
4-(dicyclo oneself-4-ketone-4 '-yl) methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (Ii) and methoxymethyl triphenylphosphine muriate are scattered in THF, the THF solution that adds potassium tert.-butoxide at 0~5 DEG C of interior temperature, stirs 2 hours.After adding water, desolventizing is heated up in a steamer in decompression, adds hexene filtering separation solid ingredient in residue.Filtrate is utilized 50% methanol aqueous solution, and water and saturated aqueous common salt are cleaned, and use anhydrous magnesium sulfate drying.Desolventizing is heated up in a steamer in decompression, adds 10% hydrochloric acid and THF in residue, adds and refluxes 1 hour.Divide and get organic layer, utilize methylbenzene extraction water layer.Merge organic layer and utilize saturated aqueous common salt to clean, with reducing pressure and heat up in a steamer desolventizing after anhydrous sodium sulfate drying.In residue, add triethylamine, THF and methyl alcohol.Then add therein 30% aqueous sodium hydroxide solution, at 5 DEG C, stir 3 hours.After adding water, with 10% hydrochloric acid neutralization, add THF and toluene.Divide and get organic layer, heat up in a steamer desolventizing with decompression after anhydrous magnesium sulfate drying, obtain 4-(anti-, own-the 4 '-yl of trans-4-formyloxy dicyclo) methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (Ij).Compound (Ij), prepares intermediate of great use as liquid crystalline cpd.
MS m/z:420(M +)
1H-NMR(60MHz,CDCl 3)
δ:1.3–2.0(m,23H),2.2–2.4(m,1H),3.8–4.0(m,4H),4.9–5.1(m,2H),5.6–5.8(m,1H),6.4–6.6(m,2H),9.6–9.8(m,1H)
1-6:4-(anti-, trans-4-vinyl dicyclo oneself-4 '-yl) methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (If) synthetic
Figure BDA00002712071900151
Methyl triphenyl phosphine bromide is scattered in THF, adds below potassium tert.-butoxide at 0 DEG C, stirs 30 points of stirrings.Splash into 4-(anti-, own-the 4 '-yl of trans-4-formyloxy dicyclo) methoxyl group-2, the THF solution of the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (Ij), stirs 1 hour.After adding acetone and water, desolventizing is heated up in a steamer in decompression, adds hexene leaching solid ingredient in residue.Filtrate utilizes 50% methanol aqueous solution, water and saturated aqueous common salt to clean, and uses anhydrous magnesium sulfate drying.Desolventizing is heated up in a steamer in decompression, and residue utilizes column chromatography and recrystallize to refine, and obtains 4-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (If).Compound (If), as the component parts of liquid-crystal composition of great use.
Embodiment 2:4-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-2, synthetic 2 of the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (If)
2-1: adopt with the synthetic 3-[4 of the same method of 1-1 in embodiment 1, own-the 4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-1,2-difluorobenzene (Ia).
2-2:3-(dicyclo oneself-4-ketone-4 '-yl) methoxyl group-1,2-difluorobenzene (Ib) synthetic
Figure BDA00002712071900152
3-[4, oneself-4 '-yl of 4-(ethylidene dioxy) dicyclo] methoxyl group-1,2-difluorobenzene (Ia) 111g is dissolved in toluene 330mL, stirs 2 hours after adding formic acid 270mL at 50 DEG C.Be cooled to after room temperature, the 200mL that adds water divides and gets organic layer, extracts water layer with toluene 300mL.After merging organic layer, utilize water, saturated sodium bicarbonate aqueous solution and saturated aqueous common salt to clean, with reducing pressure and heat up in a steamer desolventizing after anhydrous magnesium sulfate drying.Residue recrystallize is refining obtains 3-(dicyclo oneself-4-ketone-4 '-yl) methoxyl group-1,2-difluorobenzene (Ib) 95g.Compound (Ib), prepares intermediate of great use as liquid crystalline cpd.
MS m/z:322(M +)
1H-NMR(60MHz,CDCl 3)
δ:1.6–2.0(m,15H),2.0–2.4(m,4H),3.8–4.0(m,2H),6.4–6.6(m,2H),6.8–7.0(m,1H)
2-3:3-(anti-, trans-4-formyloxy dicyclo oneself-4 '-yl) methoxyl group-1,2-difluorobenzene (Ic) synthetic
Figure BDA00002712071900161
3-(dicyclo oneself-4-ketone-4 '-yl) methoxyl group-1,2-difluorobenzene (Ib) 95g and methoxymethyl triphenylphosphine muriate 132g are scattered in THF650mL, at 0~5 DEG C of interior temperature, add the THF(180mL of potassium tert.-butoxide 44g) solution, stirs 2 hours.Desolventizing is heated up in a steamer in the decompression after 25mL that adds water, and adds hexene 700mL leaching solid ingredient in residue.Filtrate is utilized 50% methanol aqueous solution, and water and saturated aqueous common salt are cleaned, and use anhydrous magnesium sulfate drying.Desolventizing is heated up in a steamer in decompression, adds 10% hydrochloric acid 300mL and THF 400mL, reflux 1 hour in residue.Divide and get organic layer, utilize toluene 300mL to extract water layer.After merging organic layer, utilize saturated aqueous common salt to clean, with reducing pressure and heat up in a steamer desolventizing after anhydrous sodium sulfate drying.In residue, add triethylamine 8mL, THF 250mL and methyl alcohol 400mL.Wherein add again 30% aqueous sodium hydroxide solution 20mL, at 5 DEG C, stir 3 hours.Add water after 600mL with 10% hydrochloric acid neutralization, add THF 300mL and toluene 700mL.Divide and get organic layer, heat up in a steamer desolventizing with decompression after anhydrous magnesium sulfate drying, obtain 3-(anti-, own-the 4 '-yl of trans-4-formyloxy dicyclo) methoxyl group-1,2-difluorobenzene (Ic) 99g.Compound (Ic), prepares intermediate of great use as liquid crystalline cpd.
MS m/z:336(M +)
1H-NMR(60MHz,CDCl 3)
δ:1.3–2.0(m,19H),2.2–2.4(m,1H),3.8–4.0(m,2H),6.4–6.6(m,2H),6.8–7.0(m,1H),9.6–9.8(m,1H)
2-4:3-(anti-, trans-4-vinyl dicyclo oneself-4 '-yl) methoxyl group-1,2-difluorobenzene (Id) synthetic
Methyl triphenyl phosphine bromide 136g is scattered in THF340mL, adds below potassium tert.-butoxide 46g at 0 DEG C, stirs 30 points.Drip 3-(anti-, own-the 4 '-yl of trans-4-formyloxy dicyclo) methoxyl group-1, the THF(200mL of 2-difluorobenzene (Ic) 99g) solution, stirs 1 hour.After adding acetone 15mL and water 15mL, desolventizing is heated up in a steamer in decompression, adds hexene 500mL leaching solid ingredient in residue.Filtrate utilizes 50% methanol aqueous solution, water and saturated aqueous common salt to clean, and uses anhydrous magnesium sulfate drying.Desolventizing is heated up in a steamer in decompression, and residue utilizes column chromatography and recrystallize to refine, and obtains 3-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-1,2-difluorobenzene (Id) 81g.Compound (Id), prepares intermediate of great use as liquid crystalline cpd.
MS m/z:334(M +)
1H-NMR(60MHz,CDCl 3)
δ:1.3–2.2(m,20H),3.8–4.0(m,2H),4.8–5.0(m,2H),5.7–5.9(m,1H),6.4–6.6(m,2H),6.8–7.0(m,1H)
2-5:4-(anti-, trans-4-vinyl dicyclo oneself-4 '-yl) methoxyl group-2,3-difluorophenol (Ie) synthetic
Figure BDA00002712071900171
3-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-1,2-difluorobenzene (Id) 39g is dissolved in THF 320mL.At Nei Wen-60 DEG C, add secondary BuLi(0.95M tetrahydrobenzene solution) 196mL, stirs 2 hours.At Nei Wen-60 DEG C, add the THF(42mL of trimethyl borate 21g) solution, be warming up to 0 DEG C.The 7.2mL that adds water adds 30% hydrogen peroxide 34mL after stirring 10 points, stirs 5 hours at 35 DEG C.Add after 10% aqueous solution of sodium bisulfite with 10% hydrochloric acid neutralization, point get organic layer.Utilize 120mL methylbenzene extraction water layer, after merging organic layer, utilize 10% salt solution to clean, utilize anhydrous sodium sulfate drying.Desolventizing is heated up in a steamer in decompression, refining 4-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-2,3-difluorophenol (Ie) 36g of obtaining of residue recrystallize.Compound (Ie), prepares intermediate of great use as liquid crystalline cpd.
MS m/z:350(M +)
1H-NMR(60MHz,CDCl 3)
δ:1.3–2.2(m,20H),3.8–4.0(m,2H),4.8–5.0(m,2H),5.7–5.9(m,1H),6.3–6.5(m,2H),4.0–6.0(s,1H)
2-6:4-(anti-, trans-4-vinyl dicyclo oneself-4 '-yl) methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (If) synthetic
Figure BDA00002712071900172
The bromo-1-amylene of 5-, 4-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-2,3-difluorophenol (Ie), Tripotassium phosphate and DMF mix, and stir 2 hours at 130 DEG C.Add water, utilize methylbenzene extraction, after organic layer utilizes water and saturated aqueous common salt to clean, desolventizing is heated up in a steamer in decompression.Residue utilizes column chromatography and recrystallize to refine, and obtains 4-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-2, the fluoro-1-of 3-bis-(4-amylene oxygen) benzene (If).Compound (If), as the formation portion material of liquid-crystal composition of great use.
Phase inversion temperature: C 75.6 N 195.2 I
MS m/z:418(M +)
1H-NMR(400MHz,CDCl 3)
δ:0.95–1.15(m,10H),1.65–2.00(m,12H),2.20–2.30(m,2H),3.76(d,J=6.4Hz,2H),3.98(t,J=6.8Hz,2H),4.87(d,J=10.0Hz,1H),4.95(d,J=17.2Hz,1H),5.00(d,J=10.4Hz,1H),5.05(d,J=17.2Hz,1H),5.77(ddd,J=17.2Hz,J=10.4Hz,J=6.4Hz,1H),5.84(ddt,J=16.8Hz,J=13.6Hz,J=6.8Hz,1H),6.55–6.65(m,2H)
Embodiment 3:4-(anti-, trans-4-vinyl dicyclo oneself-4 '-yl) methoxyl group-2, the fluoro-1-of 3-bis-(3-butylene oxygen) benzene (IIf) synthetic
Figure BDA00002712071900181
In embodiment 1 or 2, replace the bromo-1-amylene of 5-to use the bromo-1-butylene of 4-, carry out same reaction, obtain 4-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-2, the fluoro-1-of 3-bis-(3-butylene oxygen) benzene (IIf).
Phase inversion temperature C 64.5 N 119.5 I
MS m/z:404(M +),55(100)
1H-NMR(400MHz,CDCl 3)
δ:0.95-1.15(m,10H),1.65-2.00(m,10H),2.50–2.60(m,2H),3.76(d,J=6.4Hz,2H),4.03(t,J=6.8Hz,2H),4.80–5.30(m,4H),5.79(ddd,J=17.2Hz,J=10.4Hz,J=6.4Hz,1H),5.83–5.95(m,1H),6.55–6.70(m,2H)
Embodiment 4:4-(anti-, trans-4-vinyl dicyclo oneself-4 '-yl) methoxyl group-2, the fluoro-1-of 3-bis-(trans-4-ethyl cyclohexyl) anisole (IIIf) synthetic
Figure BDA00002712071900182
In embodiment 1 or 2, replace the bromo-1-amylene of 5-to use trans-4-(ethyl cyclohexyl) monobromethane, carry out same reaction, obtain 4-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-2, the fluoro-1-of 3-bis-(trans-4-ethyl cyclohexyl) anisole (IIIf).
Phase inversion temperature C 94.1 N 197.5 I
MS m/z:474(M +),146(100)
1H-NMR(400MHz,CDCl 3)
δ:0.88(t,J=7.2Hz,3H),0.90–1.30(m,17H),1.65–2.00(m,15H),3.70–3.80(m,4H),4.80–5.00(m,2H),5.77(ddd,J=16.8Hz,J=10.4Hz,J=6.4Hz,1H),6.59(d,J=5.6Hz,2H)
Embodiment 5:4-(anti-, trans-4-vinyl dicyclo oneself-4 '-yl) methoxyl group-2, the fluoro-1-of 3-bis-(trans-4-vinyl cyclohexyl) anisole (IVf) synthetic
Figure BDA00002712071900191
In embodiment 1 or 2, replace the bromo-1-amylene of 5-to use the trans-4-of methanesulfonic (vinyl cyclohexyl) methyl, carry out same reaction, obtain 4-(anti-, own-the 4 '-yl of trans-4-vinyl dicyclo) methoxyl group-2, the fluoro-1-of 3-bis-(trans-4-vinyl cyclohexyl) anisole (IVf).
Phase inversion temperature C 86.5 N 205.8 I
MS m/z:472(M +),146(100)
1H-NMR(400MHz,CDCl 3)
δ:0.95–1.25(m,14H),1.65–2.00(m,16H),3.77(t,J=7.2Hz,4H),4.85–5.05(m,4H),5.70–5.85(m,2H),6.60(d,J=5.6Hz,2H)
Industrial utilizability
The inventive method as the preparation method of liquid crystalline cpd of great use.Compound of the present invention is prepared intermediate also of great use as liquid crystalline cpd in addition.

Claims (2)

1. suc as formula a compound shown in (3),
Figure FDA00002712071800011
2. suc as formula a compound shown in (4),
Figure FDA00002712071800012
CN201310004873.5A 2006-03-31 2007-03-30 Method for producing difluorobenzene derivative Active CN103145542B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2006-097463 2006-03-31
JP2006097463 2006-03-31
JP2006-097462 2006-03-31
JP2006097462 2006-03-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2007100913768A Division CN101045677B (en) 2006-03-31 2007-03-30 Method for preparing difluorobenzene derivatives

Publications (2)

Publication Number Publication Date
CN103145542A CN103145542A (en) 2013-06-12
CN103145542B true CN103145542B (en) 2014-06-25

Family

ID=43100978

Family Applications (4)

Application Number Title Priority Date Filing Date
CN2007100913768A Active CN101045677B (en) 2006-03-31 2007-03-30 Method for preparing difluorobenzene derivatives
CN201310004873.5A Active CN103145542B (en) 2006-03-31 2007-03-30 Method for producing difluorobenzene derivative
CN 201110208203 Active CN102344434B (en) 2006-03-31 2007-03-30 Method for preparing difluorobenzene derivatives
CN 201010105726 Active CN101891598B (en) 2006-03-31 2007-03-30 Method for producing difluorobenzene derivative

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN2007100913768A Active CN101045677B (en) 2006-03-31 2007-03-30 Method for preparing difluorobenzene derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN 201110208203 Active CN102344434B (en) 2006-03-31 2007-03-30 Method for preparing difluorobenzene derivatives
CN 201010105726 Active CN101891598B (en) 2006-03-31 2007-03-30 Method for producing difluorobenzene derivative

Country Status (1)

Country Link
CN (4) CN101045677B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0885861A1 (en) * 1995-11-20 1998-12-23 Chisso Corporation (Sadao Nogi) Liquid-crystal compounds bearing vinyl linkages and liquid-crystal composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3807801A1 (en) * 1988-03-10 1989-09-21 Merck Patent Gmbh DERIVATIVES OF 2,3-DIFLUORHYDROQUINONE
JP4214580B2 (en) * 1997-12-22 2009-01-28 Dic株式会社 Nematic liquid crystal composition and liquid crystal display device using the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0885861A1 (en) * 1995-11-20 1998-12-23 Chisso Corporation (Sadao Nogi) Liquid-crystal compounds bearing vinyl linkages and liquid-crystal composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JP特开平11-241068A 1999.09.07

Also Published As

Publication number Publication date
CN103145542A (en) 2013-06-12
CN101891598B (en) 2013-04-17
CN102344434B (en) 2013-09-25
CN101045677B (en) 2011-12-28
CN101891598A (en) 2010-11-24
CN102344434A (en) 2012-02-08
CN101045677A (en) 2007-10-03

Similar Documents

Publication Publication Date Title
Palomas et al. Synthesis and reactivity of electron poor allenes: formation of completely organic frustrated Lewis pairs
CN1995030B (en) Difluoro bezene derivative production method and produced intermediate
JP4924863B2 (en) Method for producing difluorobenzene derivative
JP5056118B2 (en) Method for producing difluorobenzene derivative
CN103145542B (en) Method for producing difluorobenzene derivative
CN107513056B (en) A kind of synthetic method of the quinolines of the group containing tetrahydrofuran
CN104788480A (en) A method of synthesizing aminophenylboronic acid pinacol ester
Jensen et al. Synthesis and structure determination of Os3 [1, 2-. mu.-H; 1, 2-. mu.-O: C (Me)][1-C (OMe) Me][CO) 9: the first cluster complex containing a Fischer-type carbene group
CN106366105B (en) A kind of preparation method and applications of difluoro allyl boronate
CN113173908B (en) Preparation method of thiophene compound
JP2007204389A (en) Method for producing difluorobenzene derivative
CN101967075A (en) Method for synthesizing terminal alkyne compound by using 3-aryl-2,3-dibromopropionic acid
CN111362795B (en) Preparation method of substituted butyrate derivatives
Wang et al. Synthesis of 2‐benzylthio‐5‐phenyl‐3, 4‐disubstituted thiophenes by intramolecular condensation of α‐oxo ketene dibenzyl‐thioacetals
CN109851538B (en) Method and compound for preparing gamma-aryl nitrile
JP4983009B2 (en) Method for producing difluorobenzene derivative
EP1460079B1 (en) Dihydroxy(3-pyridyl)borane compounds
CN104926747B (en) The preparation method and use of Huan Ji oxazolin ligands with optical activation
Yus et al. Six-and five-membered 3-alkoxy-2-lithiocycloalkenes: new stable non-anionic β-functionalised organolithium compounds
CN103183591B (en) 4 '-dialkoxymethyl bis cyclohexane-4-base methyl alcohol and manufacture method thereof
EP1700852A1 (en) Processes for producing alkyl 3-(4-tetrahydropyranyl)-3-oxopropionate compound and 4-acyltetrahydropyran
Vogelgesang et al. Chiral Chelate Ligands Based on a Neopentane Framework; Introducing Indenyl and Fluorenyl Donor Groups
KR101590592B1 (en) Manufacturing method of dipyrryl ketones and dipyrryl ketones made by the same
CN110078746A (en) A kind of 2- carbonyl thiazole bithiophene class compound and the preparation method and application thereof with luminescent properties
CN102516180A (en) Preparation method of imidazole chiral ionic liquid replaced by C-2

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address

Address after: Tokyo, Japan

Patentee after: DIC Corp.

Country or region after: Japan

Address before: Tokyo, Japan

Patentee before: DAINIPPON INK AND CHEMICALS, Inc.

Country or region before: Japan

TR01 Transfer of patent right

Effective date of registration: 20240521

Address after: 606 Huai'an East Road, Shijiazhuang City, Hebei Province

Patentee after: Shijiazhuang Chengzhi Yonghua Display Materials Co.,Ltd.

Country or region after: China

Address before: Tokyo, Japan

Patentee before: DIC Corp.

Country or region before: Japan